Eledon Pharmaceuticals, Inc. (ELDN) › Net IncomeEledon Pharmaceuticals, Inc. (ELDN) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$9.65M2013: -$15.72M2014: -$23.30M2015: -$45.09M2016: -$5.66M2017: -$13.12M2018: -$14.06M2019: -$16.01M2020: -$22.81M2021: -$34.51M2022: -$87.97M2023: -$116.54M2024: -$36.18M2025: -$45.62M-$45.62M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$45.62M-26.1%2024-$36.18M+69.0%2023-$116.54M-32.5%2022-$87.97M-154.9%2021-$34.51M-51.3%2020-$22.81M-42.5%2019-$16.01M-13.8%2018-$14.06M-7.2%2017-$13.12M-131.9%2016-$5.66M+87.5%2015-$45.09M-93.5%2014-$23.30M-48.1%2013-$15.72M-63.0%2012-$9.65M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share